NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent.

Author(s): Vlaar AP, Kulik W, Nieuwland R, Peters CP, Tool AT, van Bruggen R, Juffermans NP, de Korte D

Publication: Transfusion, 2011, Vol. 51, Page 2358-66

PubMed ID: 21575006 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of storage and storage solution on levels of lysophosphatidylcholines (lysoPCs) and phosphatidylcholines (PCs) as well as neutrophil priming activity in red blood cells (RBCs), platelets (Plts), and plasma.

Conclusion of Paper

Refrigerated storage of plasma or RBCs in saline-adenine-glucose-mannitol (SAGM) or did not affect levels LysoPC or PCs, but LysoPCs increased and PCs decreased with room temperature storage of plasma or Plts in plasma. The supernatant neutrophil-priming activity increased with room temperature storage of Plts in plasma but did not increase with room temperature storage of plasma. LysoPC concentrations were higher in the supernatants of RBCs in plasma than RBCs in SAGM on day 0, but no further increases in LysoPC levels in the supernatant or RBCs in plasma during refrigerated storage were observed. Replacement of the plasma with 65% or 95% SSP+ significantly decreased the LysoPC concentration and neutrophil-priming activity of Plt supernatants, but further room temperature storage only led to a slight decrease in PCs and no further changes in LysoPCs. Addition of soluble phospholipase-2 (PLA2) inhibitors did not affect LysoPC accumulation during room temperature storage of plasma, and the authors report similar findings with the addition of cytosolic PLA2, but the data was not shown.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of storage solution and refrigerated storage on neutrophil priming activity and levels of lysoPCs and PCs in RBCs. Citrate-phosphate-dextrose (CPD) blood was stored at room temperature for 12-18 h before preparation of RBCs. RBC supernatants were frozen at -80 degrees C until analysis.

    Summary of Findings:

    LysoPC and PCs did not increase in supernatants during refrigerated storage of RBCs in SAGM. Further, the supernatant neutrophil-priming activity was unaffected by refrigerated storage of RBCs in SAGM. LysoPC concentrations were higher in the supernatants of RBCs in CPD plasma than RBCs in SAGM on day 0, but no further increases were observed in LysoPC levels in the supernatant or RBCs in plasma during refrigerated storage.

    Biospecimens
    Preservative Types
    • Other Preservative
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Lipid HPLC-MS
    Small molecule HPLC-MS
    Protein Fluorometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 0 days
    7 days
    21 days
    35 days
    42 days
    49 days
    Storage Short-term storage solution SAGM
    CPD plasma with adenine
  2. Study Purpose

    The purpose of this study was to determine the effects of storage solution and room temperature storage on neutrophil priming activity and levels of lysoPCs and PCs in Plts. CPD blood was stored at room temperature for 12-18 h before preparation of Plts. Plts were stored at 22 degrees C with horizontal shaking. Plt supernatants were frozen at -80 degrees C until analysis.

    Summary of Findings:

    LysoPCs increased and PCs decreased with room temperature storage of Plts in plasma (p<0.01, all). Further, the neutrophil-priming activity of supernatants of Plts in plasma increased with increasing room temperature storage (p<0.05). Replacement of 65% of the plasma with SSP+ significantly decreased the LysoPC concentration and neutrophil-priming activity of Plt supernatants (p<0.05), but further storage of Plts in 65% SSP+ only led to a slight decrease in PCs (p<0.05) and no further changes in LysoPCs. When 95% of the plasma for Plt storage was replaced by SSP+, the LysoPC concentration was even lower than when only 65% of the plasma was replaced, and, similarly to when only 65% of the plasma was replaced, PCs in the Plt supernatant declined with room temperature storage (p<0.05). However, the supernatants of Plts stored in 95% SSP+ for 7 days had higher neutrophil-priming activity than Plts in 100% plasma or 65% SSP+.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Lipid HPLC-MS
    Small molecule HPLC-MS
    Protein Fluorometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 0 days
    5 days
    7 days
    9 days
    Storage Short-term storage solution 100% plasma
    65% SSP+ and 35% plasma
    95% SSP+ and 5% plasma
  3. Study Purpose

    The purpose of this study was to determine the effects of collection method, storage solution and room temperature storage on neutrophil priming activity and levels of lysoPCs and PCs in plasma. Cell depleted plasma, collected by apheresis, was compared to plasma obtained from CPD blood that was stored at room temperature for 12-18 h before plasma preparation. PCs were stored at 22 degrees C with horizontal shaking. PC supernatants were frozen at -80 degrees C until analysis.

    Summary of Findings:

    LysoPCs increased and PCs decreased in plasma by day 5 of room temperature storage (p<0.05, all), but there was no corresponding increase in neutrophil-priming activity, and there were no changes in LysoPCs or PCs during refrigerated storage of plasma. The authors report similar effects of room temperature storage on the LysoPC and PC content of cell-free plasma obtained by apheresis to those obtained using plasma from whole blood. Addition of soluble PLA2 inhibitors did not affect LysoPC accumulation during room temperature storage of plasma, and the authors report similar findings with the addition of cytosolic PLA2, but the data was not shown.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein Fluorometry
    Lipid HPLC-MS
    Small molecule HPLC-MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Method of fluid acquisition Apheresis
    Venipuncture
    Storage Short-term storage solution Cytosolic PLA2 inhibitor added
    Soluble PLA2 inhibitor added
    No inhibitor added
    Storage Storage duration 0 days
    5 days
    7 days
    9 days
    Storage Storage temperature 4 degrees C
    22 degrees C
    Biospecimen Aliquots and Components Centrifugation Centrifugation delays investigated

You Recently Viewed  

News and Announcements

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • Most Downloaded SOPs in January and February of 2024

  • More...